Shikonin structure
|
Common Name | Shikonin | ||
---|---|---|---|---|
CAS Number | 54952-43-1 | Molecular Weight | 288.295 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 567.4±50.0 °C at 760 mmHg | |
Molecular Formula | C16H16O5 | Melting Point | 149 °C | |
MSDS | Chinese USA | Flash Point | 311.0±26.6 °C | |
Symbol |
GHS07, GHS09 |
Signal Word | Warning |
Use of Shikonin(Rac)-Shikonin (Shikonin) possesses anti-tumor activity. (Rac)-Shikonin (Shikonin) circumvents cancer drug resistance by induction of a necroptotic death[1][2]. |
Name | Shikalkin |
---|---|
Synonym | More Synonyms |
Description | (Rac)-Shikonin (Shikonin) possesses anti-tumor activity. (Rac)-Shikonin (Shikonin) circumvents cancer drug resistance by induction of a necroptotic death[1][2]. |
---|---|
Related Catalog | |
In Vitro | Shikonin shows a similar potency toward drug-sensitive cancer cell lines (MCF-7 and HEK293) and their drug-resistant lines overexpressing P-glycoprotein, Bcl-2, or Bcl-xL, which account for most of the clinical cancer drug resistance[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 567.4±50.0 °C at 760 mmHg |
Melting Point | 149 °C |
Molecular Formula | C16H16O5 |
Molecular Weight | 288.295 |
Flash Point | 311.0±26.6 °C |
Exact Mass | 288.099762 |
PSA | 94.83000 |
LogP | 4.35 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.642 |
Symbol |
GHS07, GHS09 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H400 |
Precautionary Statements | P273 |
Hazard Codes | Xn |
RIDADR | UN 3077 9 / PGIII |
Inhibitory effect of Shikonin on Candida albicans growth.
Biol. Pharm. Bull. 35(11) , 1956-63, (2012) Our study showed that Shikonin (SK) could provide an action against almost all Candida albicans isolates tested. More importantly, to some Fluconazole (FCZ)-resistant Candida albicans, the action of S... |
|
Screening for novel quorum-sensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm.
J. Med. Microbiol. 60(Pt 12) , 1827-34, (2011) The objective of this study was to screen for novel quorum-sensing inhibitors (QSIs) from traditional Chinese medicines (TCMs) that inhibit bacterial biofilm formation. Six of 46 active components fou... |
|
Optimization of shikonin homogenate extraction from Arnebia euchroma using response surface methodology.
Molecules 18(1) , 466-81, (2013) An efficient homogenate extraction technique was employed for extracting shikonin from Arnebia euchroma. The homogenate extraction procedure was optimized and compared with other conventional extracti... |
5,8-Dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)-1,4-naphthoquinone |
1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]- |
Arnebin-4 |
1,4-Naphthoquinone, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl) |
Alkannin |
5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]-1,4-naphthoquinone |
(±)-Alkannin |
5,8-Dihydroxy-2-(1-hydroxy-4-methyl-3-penten-1-yl)-1,4-naphthoquinone |
(+)-Alkannin |
5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione |
5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-naphthoquinone |
1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-pentenyl]- |
1,4-Naphthalenedione, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-penten-1-yl)- |
Shikonin |
5,8-Dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione |